MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G/A Report for Arbutus Biopharma Corp Common Shares (ABUS)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Arbutus Biopharma Corp Common Shares
Symbol
ABUS
Shares outstanding
188,812,816 shares
Disclosed Ownership
21,524,661 shares
Ownership
11%
Form type
SCHEDULE 13G/A
Filing time
03 Feb 2025, 15:26:45 UTC
Date of event
31 Dec 2024
Next filing
11 Feb 2026
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 11% 21,524,661 0 21,511,348 Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Investment Management Inc. 11% 21,234,598 0 21,234,598 Deidre A Downes Authorized Signatory, Morgan Stanley Investment Management Inc.